XETA Technologies to provide technical support for the U.S. operations of a global pharmaceutical company

XETA Technologies (Nasdaq:XETA), a national provider of converged communications solutions for the enterprise marketplace, announced today that it has been selected by Siemens Enterprise Networks to provide technical support services for the U.S. operations of a global pharmaceutical company. XETA provides services on behalf of Siemens and other systems integrators, original equipment manufacturers and network service providers.

Beginning October, 2009, XETA will provide technical support, field support, and help desk services for the customer’s communications and IT infrastructure under a three-year contract. XETA expects annual revenue from the contract to exceed $1 million per year.

“This win is another example of how large enterprise customers are looking to XETA to provide service for multiple equipment vendors and support in migrating communications technology. Many large enterprise customers, especially those who have grown through acquisition, have made investments in both Nortel and Avaya technologies. As one of the only partners with a nationwide sales and service footprint and the highest level of accreditation from both vendors, XETA is unique in that we offer a single provider solution,” said Scott Davis, XETA’s Executive Director of Nortel Sales.

“This contract with Siemens is one of several seven-figure service wins we have had this year and reflects how XETA is building trust and momentum with our wholesale service partners,” commented Greg Forrest, CEO and President of XETA Technologies.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New target identified for potential ALS therapy